Siga Technologies (SIGA) Capital Expenditures Growth (1y) (2011 - 2025)
Siga Technologies (SIGA) Capital Expenditures Growth (1y) (2011 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 89.01 Bn | 87.15 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 35.89 Bn | 32.15 Bn | 1.97 Bn | 32.28% |
| 3 | Zoetis | 32.48 Bn | 30.54 Bn | 1.62 Bn | -38.20% |
| 4 | Takeda Pharmaceutical | 27.52 Bn | 23.46 Bn | 4.39 Bn | -15.72% |
| 5 | United Therapeutics | 23.14 Bn | 20.99 Bn | 648.10 Mn | 32.98% |
| 6 | RedHill Biopharma | 21.76 Bn | 21.76 Bn | - | - |
| 7 | Viatris | 20.35 Bn | 18.55 Bn | 1.16 Bn | -6.34% |
| 8 | Neurocrine Biosciences | 17.73 Bn | 16.41 Bn | 800.70 Mn | -86.92% |
| 9 | Elanco Animal Health | 12.56 Bn | 12.14 Bn | 785.00 Mn | -21.54% |
| 10 | Siga Technologies | 225.91 Mn | 70.95 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 1,191.19% |
| Jun 30, 2025 | -99.95% |
| Jun 30, 2024 | -89.92% |
| Mar 31, 2021 | -11.46% |
| Mar 31, 2020 | 73.18% |
| Dec 31, 2019 | -100.00% |
| Jun 30, 2019 | -100.01% |
| Dec 31, 2018 | 62.16% |
| Jun 30, 2018 | -29.15% |
| Dec 31, 2017 | 254.85% |
| Sep 30, 2017 | 1,491,700.00% |
| Jun 30, 2017 | 1,458.70% |
| Dec 31, 2016 | -71.76% |
| Sep 30, 2016 | -100.00% |
| Dec 31, 2015 | 2,027.65% |
| Dec 31, 2014 | -99.26% |
| Jun 30, 2014 | -86.98% |
| Mar 31, 2014 | -94.72% |
| Dec 31, 2013 | -10.88% |
| Sep 30, 2013 | 1,046.06% |